The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
Open accessAbstract
A PAMless base editor: CRISPR-Cas DNA base editing typically requires a specific motif for targeting known as a protospacer-adjacent motif (PAM). This requirement limits the sequences within a genome that can be targeted. Walton et al. engineered specific variants of the Streptococcus pyogenes Cas9 enzyme named SpG and SpRY that could recognize and edit a wider array of PAMs. Using SpRY, the authors were able to correct previously uneditable mutations associated with human disease. Although off-target effects were observed for these engineered Cas enzymes at levels similar to those of the wild-type enzyme, depending on the context, these engineered enzymes widen the potential applications of precision genome editing. Science , this issue p. 290
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Efforts are ongoing to develop PAM-free Cas9 molecules to eliminate PAM site constraints altogether, thereby increasing the flexibility and effectiveness of genome editingthrough structure-based rational engineering or by altering amino acid substitutions in the PAM-interacting domain (Walton et al., 2020).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Walton et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas dominates the field because of the ease of using guide RNAs directing the CRISPR complex to specific DNA sequences and the increasing ability to target most sites in the genome.121,122”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [122]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Building on this, Walton et al. (2020) introduced the SpG variant, which can recognize a broader range of NGN PAMs.”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Walton et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“These can be targeted in combination with evolved Cas9 variants such as SpCas9-NG20 or SpG.19”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“These can be targeted with SpRY.19”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Self-citationRNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13011 · Cited by 1,822
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,002
Advances in CRISPR-Cas systems for gut microbiome
Ali, N., Vora, C., Mathuria, A., Kataria, N., & Mani, I. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.07.008 · Cited by 25
CRISPR-based genome editing technology and its applications in oil crops
He, J., Zhang, K., Tang, M., Zhou, W., Chen, L., Chen, Z., & Li, M. (2021) · Oil Crop Science · doi:10.1016/j.ocsci.2021.07.002 · Cited by 24
Cao, X., Guo, J., Huang, S., Yu, W., Li, G., An, L., Li, X., Tao, W., Liu, Q., Huang, X., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.032 · Cited by 24
Translational enhancement by base editing of the Kozak sequence rescues haploinsufficiency
Ambrosini, C., Destefanis, E., Kheir, E., Broso, F., Alessandrini, F., Longhi, S., Battisti, N., Pesce, I., Dassi, E., Petris, G., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac799 · Cited by 24
Automated identification of sequence-tailored Cas9 proteins using massive metagenomic data
Ciciani, M., Demozzi, M., Pedrazzoli, E., Visentin, E., Pezzè, L., Signorini, L. F., Blanco‐Míguez, A., Zolfo, M., Asnicar, F., Casini, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34213-9 · Cited by 25
Transcription factor antagonism regulates heterogeneity in embryonic stem cell states
Hu, S., Metcalf, E., Mahat, D. B., Chan, L., Sohal, N., Chakraborty, M., Hamilton, M., Singh, A., Singh, A., Lees, J. A., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.10.022 · Cited by 24
Ren, J., Hai, T., Chen, Y., Sun, K., Han, Z., Wang, J., Li, C., Wang, Q., Wang, L., Zhu, H., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2407-0 · Cited by 26
Efficient in situ epitope tagging of rice genes by nuclease-mediated prime editing
Li, X., Zhang, S., Wang, C., Ren, B., Yan, F., Li, S., Spetz, C., Huang, J., Zhou, X., & Zhou, H. (2024) · The Plant Cell · doi:10.1093/plcell/koae316 · Cited by 24
Precision engineering of the probiotic Escherichia coli Nissle 1917 with prime editing
Chen, P.-R., Wei, Y., Li, X., Yu, H., Wang, S., Yuan, X.-Z., & Xia, P. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.00031-25 · Cited by 23
Molecular signaling pathways in osteoarthritis and biomaterials for cartilage regeneration: a review
Hiruthyaswamy, S. P., Bose, A., Upadhyay, A., Raha, T., Bhattacharjee, S., Singha, I., Ray, S., Macarius, N. M. N., Viswanathan, P., & Deepankumar, K. (2025) · Bioengineered · doi:10.1080/21655979.2025.2501880 · Cited by 24
Musolino, P. L., Rosser, S. J., Brittan, M., Newby, D. E., Berry, C., Riley, P. R., Giacca, M., Hajjar, R. J., & Baker, A. H. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf109 · Cited by 23
Compact SchCas9 Recognizes the Simple NNGR PAM
Wang, S., Mao, H., Hou, L., Hu, Z., Wang, Y., Qi, T., Tao, C., Yang, Y., Zhang, C., Li, M., et al. (2021) · Advanced Science · doi:10.1002/advs.202104789 · Cited by 24
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG
Yu, S.-Y., Birkenshaw, A., Thomson, T., Carlaw, T., Zhang, L., & Ross, C. J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0109 · Cited by 23
SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power
Zhang, D., & Zhang, B. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.05.001 · Cited by 23
Newman, A., Starrs, L. M., & Burgio, G. (2020) · BioEssays · doi:10.1002/bies.202000047 · Cited by 26
Urnov, F. D. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.019 · Cited by 26
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope
Bamidele, N., Zhang, H., Dong, X., Cheng, H., Gaston, N., Feinzig, H., Cao, H., Kelly, K. L., Watts, J. K., Xie, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45763-5 · Cited by 24
Nuccio, S. P., Cadoni, E., Nikoloudaki, R., Galli, S., Ler, A.-J., Sanchez-Cabanillas, C., Maher, T. E., Fan, E., Guneri, D., Flint, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67074-z · Cited by 25
CRISPR–Cas-mediated gene editing in lactic acid bacteria
Song, X., Zhang, X., Xiong, Z., Liu, X., Xia, Y., Wang, S., & Ai, L. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05820-w · Cited by 22
Points of View on the Tools for Genome/Gene Editing
Chuang, C.-K., & Lin, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189872 · Cited by 26
Advances and Opportunities of CRISPR/Cas Technology in Bioengineering Non-conventional Yeasts
Shan, L., Dai, Z., & Wang, Q. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.765396 · Cited by 23
From DNA break repair pathways to CRISPR/Cas-mediated gene knock-in methods
Bazaz, M. R., & Dehghani, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120409 · Cited by 23
Nasrallah, A., Sulpice, E., Kobaisi, F., Gidrol, X., & Rachidi, W. (2022) · Cells · doi:10.3390/cells11223615 · Cited by 26
Challenges of Gene Editing Therapies for Genodermatoses
Brooks, I. R., Sheriff, A., Moran, D., Wang, J., & Jackow, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032298 · Cited by 23
Giner, G., Ikram, S., Herold, M. J., & Papenfuss, A. T. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad205 · Cited by 22
Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM
Qi, T., Wang, Y., Yang, Y., Gao, S., Liu, J., Huang, Q., Tian, Y., Tang, J., Zheng, W., & Wang, Y. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01481-5 · Cited by 23
Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing
Vlashi, R., Zhang, X., Li, H., & Chen, G. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09860-y · Cited by 24
CRISPR-Cas “Non-Target” Sites Inhibit On-Target Cutting Rates
Moreb, E. A., Hutmacher, M., & Lynch, M. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0065 · Cited by 23
Alessa, O., Aiba, Y., Arbaah, M., Hidaka, Y., Watanabe, S., Miyanaga, K., Wannigama, D. L., & Cui, L. (2025) · Molecules · doi:10.3390/molecules30153132 · Cited by 21
Menon, A. V., Song, B., Chao, L., Sriram, D., Chansky, P. A., Bakshi, I., Ulianova, J., & Li, W. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1565387 · Cited by 21
Asano, Y., Yamashita, K., Hasegawa, A., Ogasawara, T., Iriki, H., & Muramoto, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-89546-0 · Cited by 24
Gradients in gene essentiality reshape antibacterial research
Hogan, A. M., & Cardona, S. T. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac005 · Cited by 24
Genetic Engineering Technologies for Improving Crop Yield and Quality
Ye, R., Yang, X., & Rao, Y. (2022) · Agronomy · doi:10.3390/agronomy12040759 · Cited by 21
Lu, Y., Mbakam, C. H., Song, B., Bendavid, E., & Tremblay, J. P. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.892769 · Cited by 22
Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants
Kiattisewee, C., Karanjia, A. V., Legut, M., Daniloski, Z., Koplik, S. E., Nelson, J., Kleinstiver, B. P., Sanjana, N. E., Carothers, J. M., & Zalatan, J. G. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00405 · Cited by 21
Self-citationKhan, F. S., Goher, F., Zhang, D., Shi, P., Li, Z., Htwe, Y. M., & Wang, Y. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.1042828 · Cited by 22
CRISPR-Cas9 base editors and their current role in human therapeutics
Lahr, W. S., Sipe, C. J., Skeate, J. G., Webber, B. R., & Moriarity, B. S. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2022.11.013 · Cited by 21
Advances in CRISPR/Cas gene therapy for inborn errors of immunity
Liu, X., Li, G., Liu, Y., Zhou, F., Huang, X., & Li, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111777 · Cited by 21
CRISPR genetic toolkits of classical food microorganisms: Current state and future prospects
Lv, X., Li, Y., Xiu, X., Liao, C., Xu, Y., Liu, Y., Li, J., Du, G., & Liu, L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108261 · Cited by 21
The Development, Optimization and Future of Prime Editing
Petrova, I. O., & Smirnikhina, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317045 · Cited by 21
Plant conservation in the age of genome editing: opportunities and challenges
Yin, K., Chung, M. Y., Lan, B., Du, F., & Chung, M. G. (2024) · Genome biology · doi:10.1186/s13059-024-03399-0 · Cited by 24
Villiger, L., Schmidheini, L., Mathis, N., Rothgangl, T., Marquart, K. F., & Schwank, G. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.025 · Cited by 21
Chen, T., Dumas, M., Watson, R., Vincoff, S., Peng, C., Zhao, L., Hong, L., Pertsemlidis, S., Shaepers-Cheu, M., Wang, T. Z., et al. (2023) · PubMed · doi:10.48550/arxiv.2310.03842 · Cited by 24
Hybrid Cas12a Variants with Relaxed PAM Requirements Expand Genome Editing Compatibility
Liu, Z., Liu, H., Huang, C., Zhou, Q., & Luo, Y. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00103 · Cited by 20
CRISPR Technology and Its Emerging Applications
Zhang, X. E., Ma, D., & Liu, F. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf034 · Cited by 21
High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase
Wu, Y., Xiao, Y., & Tang, W. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02678-w · Cited by 23
Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs
Whittaker, M. N., Testa, L. C., Quigley, A., Brooks, D. L., Grandinette, S. A., Said, H., Dwivedi, G., Jindal, I., Volpp, D., Hacker, J. L., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01545-y · Cited by 20
Self-citationSophisticated CRISPR/Cas tools for fine-tuning plant performance
Capdeville, N., Merker, L., Schindele, P., & Puchta, H. (2020) · Journal of Plant Physiology · doi:10.1016/j.jplph.2020.153332 · Cited by 21
Tissue Specific DNA Repair Outcomes Shape the Landscape of Genome Editing
Meyenberg, M., da Silva, J. F., & Loizou, J. I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.728520 · Cited by 21
Chen, S., Liu, Z., Lai, L., & Li, Z. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0124 · Cited by 21
New Hope for Genome Editing in Cultivated Grasses: CRISPR Variants and Application
Riaz, A., Kanwal, F., Ahmad, I., Ahmad, S., Farooq, A., Madsen, C. K., Brinch‐Pedersen, H., Bekalu, Z. E., Dai, F., Zhang, G., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.866121 · Cited by 20
Chen, Y., Luo, X. L., Kang, R., Cui, K., Ou, J., Zhang, X., & Liang, P. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.07.007 · Cited by 23
Genetic Databases and Gene Editing Tools for Enhancing Crop Resistance against Abiotic Stress
Joshi, A. B., Yang, S.-Y., Song, H.-G., Min, J., & Lee, J.-H. (2023) · Biology · doi:10.3390/biology12111400 · Cited by 21
Advancing PAM-less genome editing in soybean using CRISPR-SpRY
Chen, X., Zhong, Z., Tang, X. D., Yang, S., Zhang, Y., Wang, S., Liu, Y., Zheng, X., Feng, X., Zhang, Y., et al. (2024) · Horticulture Research · doi:10.1093/hr/uhae160 · Cited by 20
Engineered cytosine base editor enabling broad-scope and high-fidelity gene editing in Streptomyces
Wang, J., Wang, K., Deng, Z., Zhong, Z., Sun, G., Mei, Q., Zhou, F., Deng, Z., & Sun, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-49987-3 · Cited by 20
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
Clarissa, E. M., Karmacharya, M., Choi, H., Kumar, S., & Cho, Y. (2025) · Small · doi:10.1002/smll.202409353 · Cited by 23
Gong, G., Zhang, Y., Wang, Z., Liu, L., Shi, S., Siewers, V., Yuan, Q., Nielsen, J., Zhang, X., & Liu, Z. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00560 · Cited by 22
Genome Editing of Veterinary Relevant Mycoplasmas Using a CRISPR-Cas Base Editor System
Ipoutcha, T., Rideau, F., Gourgues, G., Arfi, Y., Lartigue, C., Blanchard, A., & Sirand-Pugnet, P. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.00996-22 · Cited by 19
Genetic Improvement of rice Grain size Using the CRISPR/Cas9 System
Zhang, T., Wang, Z., Liu, Q., & Zhao, D. (2025) · Rice · doi:10.1186/s12284-025-00758-8 · Cited by 19
Synthetic Biology of Plants and Microbes for Agriculture, Environment, and Future Applications
Clauer, P. R., Nou, A., Toth, T., Yu, Q., Chemla, Y., Boo, A., Yoon, K. S., & Voigt, C. A. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00687 · Cited by 21
Customizing CRISPR–Cas PAM specificity with protein language models
Nayfach, S., Bhatnagar, A., Novichkov, A., Kim, N., Hoffnagle, A. M., Hussain, R., Estevam, G. O., Hill, E., Ruffolo, J. A., Silverstein, R. A., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02995-0 · Cited by 19
Self-citationDevelopment of CRISPR technology for precise single-base genome editing: a brief review
Lee, H. K., Oh, Y., Hong, J., Lee, S. H., & Hur, J. K. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.2.217 · Cited by 20
CRISPR Toolbox for Genome Editing in Dictyostelium
Yamashita, K., Iriki, H., Kamimura, Y., & Muramoto, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721630 · Cited by 23
Mechanistic insights into the versatile class II CRISPR toolbox
Zhang, F., & Huang, Z. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.11.007 · Cited by 20
Huang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
Characterizing off-target effects of genome editors
Rao, X., Zhao, H., Shao, C., & Yi, C. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100480 · Cited by 19
Characterization of a thermostable Cas12a ortholog
Wu, J., Gao, P., Shi, Y., Zhang, C., Tong, X., Fan, H., Zhou, X., Zhang, Y., & Yin, H. (2023) · Cell Insight · doi:10.1016/j.cellin.2023.100126 · Cited by 19
Efficient exon skipping by base-editor-mediated abrogation of exonic splicing enhancers
Qiu, H., Li, G., Yuan, J., Yang, D., Ma, Y., Wang, F., Dai, Y., & Chang, X. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113340 · Cited by 22
Unbiased interrogation of functional lysine residues in human proteome
Bao, Y., Pan, Q., Xu, P., Liu, Z., Zhang, Z., Liu, Y., Xu, Y., Yu, Y., Zhou, Z. L., & Wei, W. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.033 · Cited by 19
CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering
Eghbalsaied, S., Lawler, C., Petersen, B., Hajiyev, R. A., Bischoff, S. R., & Frankenberg, S. (2024) · Gene Therapy · doi:10.1038/s41434-023-00434-w · Cited by 20
Base editing effectively prevents early-onset severe cardiomyopathy in Mybpc3 mutant mice
Wu, S., Yang, P., Geng, Z., Li, Y., Guo, Z., Lou, Y., Zhang, S., Xiong, J., Hu, H., Guo, X., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00930-7 · Cited by 19
Health research in the era of artificial intelligence: Advances in gene-editing study
Dai, M., Li, X., Zhang, Q., Liang, T., Huang, X., & Fu, Q. (2024) · Medicine Plus · doi:10.1016/j.medp.2024.100027 · Cited by 19
Efficient genome editing in rice with miniature Cas12f variants
Ye, Z., Zhang, Y., He, S., Li, S., Luo, L., Zhou, Y., Tan, J., & Wan, J. (2024) · aBIOTECH · doi:10.1007/s42994-024-00168-2 · Cited by 19
Structure and genome editing activity of the novel CRISPR-Cas12o1 effector
Duan, Z., Zhang, X., Zhang, J., Ji, X., Liu, R., Chen, Y., Li, S., Jia, N., Gao, H., Xin, Y., et al. (2024) · Cell Research · doi:10.1038/s41422-024-01050-y · Cited by 19
Efficient CRISPR-Cas9 based cytosine base editors for phytopathogenic bacteria
Li, C., Wang, L., Cseke, L. J., Vasconcelos, F., Huguet‐Tapia, J. C., Gassmann, W., Pauwels, L., White, F. F., Dong, H., & Yang, B. (2023) · Communications Biology · doi:10.1038/s42003-023-04451-8 · Cited by 19
Base Editing in Human Cells to Produce Single‐Nucleotide‐Variant Clonal Cell Lines
Vásquez, C. A., Cowan, Q. T., & Komor, A. C. (2020) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.129 · Cited by 20
Barazesh, M., Mohammadi, S., Bahrami, Y., Mokarram, P., Morowvat, M. H., Saidijam, M., Karimipoor, M., Kavousipour, S., Vosoughi, A. R., & Khanaki, K. (2020) · Current Gene Therapy · doi:10.2174/1566523220666201214115024 · Cited by 19
Kaukonen, M. K., McClements, M. E., & MacLaren, R. E. (2022) · Genes · doi:10.3390/genes13081327 · Cited by 19
Recursive Editing improves homology-directed repair through retargeting of undesired outcomes
Moeller, L., Aird, E. J., Schröder, M., Kobel, L., Kissling, L., van de Venn, L., & Corn, J. E. (2022) · Nature Communications · doi:10.1038/s41467-022-31944-7 · Cited by 18
Optimization of CRISPR–Cas system for clinical cancer therapy
Meng, X. L., Wu, T., Lou, Q., Niu, K., Jiang, L., Xiao, Q., Xu, T., & Zhang, L. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10474 · Cited by 18
Zhang, J.-D., Zhang, L., Zhang, C., Yang, Y., Liu, H., Li, L., Zhang, S., Li, X., Liu, X., Liu, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2396-x · Cited by 18
In vivo base editing rescues primary hyperoxaluria type 1 in rats
Chen, Z., Zhang, D., Zheng, R., Yang, L., Huo, Y., Zhang, D., Fang, X., Li, Y., Xu, G., Li, D., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.11.029 · Cited by 19
Kruglova, N. A., & Shepelev, M. V. (2024) · Biomedicines · doi:10.3390/biomedicines12010119 · Cited by 18
Continual improvement of CRISPR ‐induced multiplex mutagenesis in Arabidopsis
Develtere, W., Decaestecker, W., Rombaut, D., Anders, C., Clicque, E., Vuylsteke, M., & Jacobs, T. B. (2024) · The Plant Journal · doi:10.1111/tpj.16785 · Cited by 18
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
Lau, C., Liang, Q., & Zhu, H. (2024) · Transgenic Research · doi:10.1007/s11248-024-00404-x · Cited by 19
Genome-wide detection and analysis of CRISPR-Cas off-targets
Rodríguez, T., Dadafarin, S., Pratt, H., Liu, P., Amrani, N., & Zhu, L. J. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.012 · Cited by 19
CRISPR-Guided Programmable Self-Assembly of Artificial Virus-Like Nucleocapsids
Calcines-Cruz, C., Finkelstein, I. J., & Hernández-García, A. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04640 · Cited by 18
Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells
Haideri, T., Howells, A. R., Jiang, Y., Yang, J., Bao, X., & Lian, X. L. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100290 · Cited by 18
Spoto, M., Puma, J. P. R., Fleming, E. S., Guan, C., Ondouah-Nzutchi, Y., Kim, D., & Oh, J. (2022) · mBio · doi:10.1128/mbio.02632-22 · Cited by 18
Celotti, M., Derks, L. L. M., van Es, J., van Boxtel, R., Clevers, H., & Geurts, M. H. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103189 · Cited by 17
Advances and Applications of Plant Base Editing Technologies
Peng, H. F., Li, J., Sun, K., Tang, H., Huang, W., Li, X., Wang, S., Ding, K., Han, Z., Li, Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199452 · Cited by 20
Parallel genetics of regulatory sequences using scalable genome editing in vivo
Froehlich, J. J., Uyar, B., Herzog, M., Theil, K., Glažar, P., Akalin, A., & Rajewsky, N. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108988 · Cited by 18
Gene editing with ‘pencil’ rather than ‘scissors’ in human pluripotent stem cells
Park, J.-C., Park, M. J., Lee, S.-Y., Kim, D., Kim, K.-T., Jang, H., & Cha, H. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03394-5 · Cited by 17
Doll, R. M., Boutros, M., & Port, F. (2023) · Science Advances · doi:10.1126/sciadv.adj1568 · Cited by 18
CRISPR/Cas in Grapevine Genome Editing: The Best Is Yet to Come
Ren, C., Mohamed, M. S. M., Aini, N., Kuang, Y., & Liang, Z. (2024) · Horticulturae · doi:10.3390/horticulturae10090965 · Cited by 18
Zhang, Y., Liu, Y., Qin, W., Zheng, S., Xia, X., Xia, X., Yuan, X., Zeng, J., Shi, Y., Zhang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53735-y · Cited by 17
Recent advances in CRISPR technologies for genome editing
Song, M., & Koo, T. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01336-4 · Cited by 18
CRISPR/Cas correction of muscular dystrophies
Zhang, Y., Nishiyama, T., Olson, E. N., & Bassel‐Duby, R. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112844 · Cited by 18
Decrypting the mechanistic basis of CRISPR/Cas9 protein
Panda, G., & Ray, A. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.05.001 · Cited by 17
CRISPRactivation-SMS, a message for PAM sequence independent gene up-regulation in Escherichia coli
Klanschnig, M., Cserjan‐Puschmann, M., Striedner, G., & Grabherr, R. M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac804 · Cited by 18
Metadata
- Authors
- Walton, R. T., Christie, K. A., Whittaker, M. N., & Kleinstiver, B. P.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Kleinstiver, Benjamin P.
- Venue
- Science
- Published
- 2020-04-17
- Volume
- 368
- Issue
- 6488
- Pages
- 290-296
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7297043
- OpenAlex
- W3013504322
- Semantic Scholar
- 84609b61a82a11e3122a81b5bdae20a2822e577b
- Cited by
- 1,233
- References
- 48
- Citations by year
- 2026: 157 · 2025: 200 · 2024: 190 · 2023: 213 · 2022: 203 · 2021: 177 · 2020: 93
- FWCI
- 56.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01-HL142494)
- National Cancer Institute (R00-CA218870)
- American Society of Gene and Cell Therapy
- Margaret Q. Landenberger Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, SPG, SpRY, base editing, genome editing, human cells
- MeSH terms
- Protein Domains, Gene Editing, CRISPR-Associated Protein 9, Humans, Substrate Specificity, Mutagenesis, Gene Targeting, Genetic Predisposition to Disease, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review